Structural and Functional MRI in Familial Parkinson's Disease

Agosta, 2013, White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations, Movement Disorders, 28, 772, 10.1002/mds.25397 Alcalay, 2013, Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations, Movement Disorders, 28, 1966, 10.1002/mds.25647 Anders, 2012, Compensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele, Brain, 135, 1128, 10.1093/brain/aws040 Ashburner, 2000, Voxel-based morphometry—The methods, NeuroImage, 11, 805, 10.1006/nimg.2000.0582 Atkinson-Clement, 2017, Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis, Neuroimage. Clinical, 16, 98, 10.1016/j.nicl.2017.07.011 Barulli, 2013, Efficiency, capacity, compensation, maintenance, plasticity: Emerging concepts in cognitive reserve, Trends in Cognitive Sciences, 17, 502, 10.1016/j.tics.2013.08.012 Basser, 1996, Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI, Journal of Magnetic Resonance. Series B, 111, 209, 10.1006/jmrb.1996.0086 Berg, 2015, MDS research criteria for prodromal Parkinson's disease, Movement Disorders, 30, 1600, 10.1002/mds.26431 Bilgic, 2012, Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: Contribution of automated segmentation neuroimaging method, Parkinsonism & Related Disorders, 18, 562, 10.1016/j.parkreldis.2012.02.017 Binkofski, 2007, Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia, Neurology, 69, 842, 10.1212/01.wnl.0000267844.72421.6c Bonifati, 2003, DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism, Neurological Sciences, 24, 159, 10.1007/s10072-003-0108-0 Bregman, 2017, A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers, Brain Structure & Function, 222, 1207, 10.1007/s00429-016-1271-4 Brockmann, 2011, Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers, Movement Disorders, 26, 2335, 10.1002/mds.23991 Buhmann, 2005, Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: A human model for presymptomatic parkinsonism, Brain, 128, 2281, 10.1093/brain/awh572 Burciu, 2018, Multimodal neuroimaging and behavioral assessment of alpha-synuclein polymorphism rs356219 in older adults, Neurobiology of Aging, 66, 32, 10.1016/j.neurobiolaging.2018.02.001 Chang, 2017, A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci, Nature Genetics, 49, 1511, 10.1038/ng.3955 Correia Guedes, 2017, Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease, Movement Disorders, 32, 1331, 10.1002/mds.27083 Desikan, 2006, An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest, NeuroImage, 31, 968, 10.1016/j.neuroimage.2006.01.021 Fornito, 2015, The connectomics of brain disorders, Nature Reviews Neuroscience, 16, 159, 10.1038/nrn3901 Gan-Or, 2008, Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset, Neurology, 70, 2277, 10.1212/01.wnl.0000304039.11891.29 Gattellaro, 2009, White matter involvement in idiopathic Parkinson disease: A diffusion tensor imaging study, AJNR. American Journal of Neuroradiology, 30, 1222, 10.3174/ajnr.A1556 Grady, 2008, Cognitive neuroscience of aging, Annals of the New York Academy of Sciences, 1124, 127, 10.1196/annals.1440.009 Haacke, 2005, Imaging iron stores in the brain using magnetic resonance imaging, Magnetic Resonance Imaging, 23, 1, 10.1016/j.mri.2004.10.001 Healy, 2008, Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: A case-control study, Lancet Neurology, 7, 583, 10.1016/S1474-4422(08)70117-0 Helmich, 2010, Spatial remapping of cortico-striatal connectivity in Parkinson's disease, Cerebral Cortex, 20, 1175, 10.1093/cercor/bhp178 Helmich, 2015, Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers, Neurology, 84, 399, 10.1212/WNL.0000000000001189 Hou, 2018, Altered intrinsic brain functional connectivity in drug-naive Parkinson's disease patients with LRRK2 mutations, Neuroscience Letters, 675, 145, 10.1016/j.neulet.2018.03.038 Hou, 2016, Patterns of striatal functional connectivity differ in early and late onset Parkinson's disease, Journal of Neurology, 263, 1993, 10.1007/s00415-016-8211-3 Hu, 2006, Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease, Movement Disorders, 21, 299, 10.1002/mds.20702 Jahanshahi, 1995, Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects, Brain, 118, 913, 10.1093/brain/118.4.913 Kasten, 2013, The many faces of alpha-synuclein mutations, Movement Disorders, 28, 697, 10.1002/mds.25499 Lee, 2013, Early cortical gray matter loss and cognitive correlates in non-demented Parkinson's patients, Parkinsonism & Related Disorders, 19, 1088, 10.1016/j.parkreldis.2013.07.018 Lee, 2017, Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry, Movement Disorders, 32, 1432, 10.1002/mds.27059 Lesage, 2009, Parkinson's disease: From monogenic forms to genetic susceptibility factors, Human Molecular Genetics, 18, R48, 10.1093/hmg/ddp012 Lin, 2014, Genetics and genomics of Parkinson's disease, Genome Medicine, 6, 48, 10.1186/gm566 Liu, 2016, Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson’s, Annals of Neurology, 80, 674, 10.1002/ana.24781 Logothetis, 2008, What we can do and what we cannot do with fMRI, Nature, 453, 869, 10.1038/nature06976 Lohmann, 2003, How much phenotypic variation can be attributed to parkin genotype?, Annals of Neurology, 54, 176, 10.1002/ana.10613 Makovac, 2016, Brain connectivity changes in autosomal recessive Parkinson disease: A model for the sporadic form, PLoS One, 11, 10.1371/journal.pone.0163980 McNeill, 2013, Dopaminergic neuronal imaging in genetic Parkinson's disease: Insights into pathogenesis, PLoS One, 8, 10.1371/journal.pone.0069190 Migdalska-Richards, 2016, The relationship between glucocerebrosidase mutations and Parkinson disease, Journal of Neurochemistry, 139, 77, 10.1111/jnc.13385 Minnerop, 2007, Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters, NeuroImage, 36, 1086, 10.1016/j.neuroimage.2007.04.028 Mirelman, 2011, Gait alterations in healthy carriers of the LRRK2 G2019S mutation, Annals of Neurology, 69, 193, 10.1002/ana.22165 Mirelman, 2013, Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation, Movement Disorders, 28, 1683, 10.1002/mds.25587 Morrish, 1998, Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET, Journal of Neurology, Neurosurgery, and Psychiatry, 64, 314, 10.1136/jnnp.64.3.314 Neumann, 2009, Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease, Brain, 132, 1783, 10.1093/brain/awp044 Planetta, 2016, Free-water imaging in Parkinson's disease and atypical parkinsonism, Brain, 139, 495, 10.1093/brain/awv361 Postuma, 2015, MDS clinical diagnostic criteria for Parkinson's disease, Movement Disorders, 30, 1591, 10.1002/mds.26424 Pyatigorskaya, 2015, High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry, Movement Disorders, 30, 1077, 10.1002/mds.26218 Reetz, 2009, Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson's disease, Movement Disorders, 24, 99, 10.1002/mds.22333 Reetz, 2008, Limbic and frontal cortical degeneration is associated with psychiatric symptoms in PINK1 mutation carriers, Biological Psychiatry, 64, 241, 10.1016/j.biopsych.2007.12.010 Reetz, 2010, Structural imaging in the presymptomatic stage of genetically determined parkinsonism, Neurobiology of Disease, 39, 402, 10.1016/j.nbd.2010.05.006 Sabatini, 2000, Cortical motor reorganization in akinetic patients with Parkinson's disease: A functional MRI study, Brain, 123, 394, 10.1093/brain/123.2.394 Samaranch, 2010, PINK1-linked parkinsonism is associated with Lewy body pathology, Brain, 133, 1128, 10.1093/brain/awq051 Scheller, 2014, Attempted and successful compensation in preclinical and early manifest neurodegeneration—A review of task FMRI studies, Frontiers in Psychiatry, 5, 132, 10.3389/fpsyt.2014.00132 Scherfler, 2004, Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism, Brain, 127, 1332, 10.1093/brain/awh150 Sian-Hulsmann, 2011, The relevance of iron in the pathogenesis of Parkinson's disease, Journal of Neurochemistry, 118, 939, 10.1111/j.1471-4159.2010.07132.x Sidransky, 2009, Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease, The New England Journal of Medicine, 361, 1651, 10.1056/NEJMoa0901281 Stern, 2009, Cognitive reserve, Neuropsychologia, 47, 2015, 10.1016/j.neuropsychologia.2009.03.004 Szamosi, 2013, Delay discounting of reward and caudate nucleus volume in individuals with alpha-synuclein gene duplication before and after the development of Parkinson's disease, Neurodegenerative Diseases, 11, 72, 10.1159/000341997 Thaler, 2014, A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers, Movement Disorders, 29, 823, 10.1002/mds.25827 Thaler, 2009, The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews, Journal of Neural Transmission, 116, 1473, 10.1007/s00702-009-0303-0 Thaler, 2018, Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene, Parkinsonism & Related Disorders, 10.1016/j.parkreldis.2018.05.009 Thaler, 2018, Altered reward-related neural responses in non-manifesting carriers of the Parkinson disease related LRRK2 mutation, Brain Imaging and Behavior, 10.1007/s11682-018-9920-2 Thaler, 2016, Intact working memory in non-manifesting LRRK2 carriers—An fMRI study, The European Journal of Neuroscience, 43, 106, 10.1111/ejn.13120 Thaler, 2018, Cerebral imaging markers of GBA and LRRK2 related Parkinson's disease and their first-degree unaffected relatives, Brain Topography, 10.1007/s10548-018-0653-8 Thaler, 2013, Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers, Cortex, 49, 2501, 10.1016/j.cortex.2012.12.017 Trachtenberg, 2002, Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex, Nature, 420, 788, 10.1038/nature01273 Trinh, 2014, Disease penetrance of late-onset Parkinsonism: A meta-analysis, JAMA Neurology, 71, 1535, 10.1001/jamaneurol.2014.1909 van Eimeren, 2010, Imaging movement-related activity in medicated Parkin-associated and sporadic Parkinson's disease, Parkinsonism & Related Disorders, 16, 384, 10.1016/j.parkreldis.2010.04.003 van Nuenen, 2012, Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism, Brain, 135, 3687, 10.1093/brain/aws288 van Nuenen, 2009, Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype, Neurology, 72, 1041, 10.1212/01.wnl.0000338699.56379.11 Vilas, 2016, Nigral and striatal connectivity alterations in asymptomatic LRRK2 mutation carriers: A magnetic resonance imaging study, Movement Disorders, 31, 1820, 10.1002/mds.26799 Zabetian, 2006, LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: Evidence of two distinct founding events beginning two millennia ago, American Journal of Human Genetics, 79, 752, 10.1086/508025